The Hunt for New Antibiotics

Bacterial infections are responsible for one quarter of all deaths, a number that may rise with the alarming increase in multi-drug resistant strains.


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Bacterial infections are responsible for one quarter of all deaths, a number that may rise with the alarming increase in multi-drug resistant strains. On page 20 of this feature on antibiotics, Jo Handelsman, of the University of Wisconsin, Madison, writes that applying metagenomic approaches may yield new treatments. "Most of the antibiotics used today are derived from cultured soil bacteria, but these organisms represent only the tip of a microbiological iceberg" she says. But first we take a look at how stopping bacterial evolution could improve the power of new drugs and bolster the ones already at hand.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development